Litcius/Paper detail

Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages

Aaron Volk, Matthew Hackbart, Xufang Deng, Yazmin E. Cruz-Pulido, Amornrat O’Brien, Susan C. Baker

2020Journal of Virology42 citationsDOIOpen Access PDF

Abstract

Macrophages are an important cell type during coronavirus infections because they "notice" the infection and respond by inducing type I interferons, which limits virus replication. In turn, coronaviruses encode proteins that mitigate the cell's ability to signal an interferon response. Here, we evaluated the host macrophage response to two independent mutant coronaviruses, one with reduced deubiquitinating activity (DUBmut) and the other containing an inactivated endoribonuclease (EndoUmut). We observed a rapid, robust, and focused response to the EndoUmut virus, which was characterized by enhanced expression of interferon and interferon-related genes. In contrast, wild-type virus and the DUBmut virus elicited a more limited interferon response and ultimately activated over 2,800 genes, including players in the unfolded protein response and proinflammatory pathways associated with progression of significant disease. This study reveals that EndoU activity substantially contributes to the ability of coronaviruses to evade the host innate response and to replicate in macrophages.

Topics & Concepts

BiologyInterferonVirologyViral replicationVirusInnate immune systemCoronavirusInterferon type IProinflammatory cytokineImmunologyImmune systemInflammationCoronavirus disease 2019 (COVID-19)PathologyMedicineDiseaseInfectious disease (medical specialty)interferon and immune responsesSARS-CoV-2 and COVID-19 ResearchImmune cells in cancer